[
  {
    "ts": "2025-09-18T13:09:58+00:00",
    "headline": "Drug distributor McKesson to restructure segments to focus on high-margin businesses",
    "summary": "The restructuring will reflect how CEO Brian Tyler will allocate resources and assess performance going forward, but does not affect previously issued financial statements or historical earnings per share, the company said.  \"This updated reporting structure reflects a strategic evolution of our business – accelerating growth in the high-margin areas of oncology, multispecialty, and biopharma services,\" Chief Financial Officer Britt Vitalone said in a statement.  Starting this quarter, its second in fiscal 2026, the Texas-based firm will reorganize into North American pharmaceutical, oncology and multispecialty, prescription technology solutions, and medical-surgical solutions segments, the company said.",
    "url": "https://ca.finance.yahoo.com/news/drug-distributor-mckesson-restructure-segments-130958006.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "408cbd70-85ef-3624-b82d-d45953c29c4a",
      "content": {
        "id": "408cbd70-85ef-3624-b82d-d45953c29c4a",
        "contentType": "STORY",
        "title": "Drug distributor McKesson to restructure segments to focus on high-margin businesses",
        "description": "",
        "summary": "The restructuring will reflect how CEO Brian Tyler will allocate resources and assess performance going forward, but does not affect previously issued financial statements or historical earnings per share, the company said.  \"This updated reporting structure reflects a strategic evolution of our business – accelerating growth in the high-margin areas of oncology, multispecialty, and biopharma services,\" Chief Financial Officer Britt Vitalone said in a statement.  Starting this quarter, its second in fiscal 2026, the Texas-based firm will reorganize into North American pharmaceutical, oncology and multispecialty, prescription technology solutions, and medical-surgical solutions segments, the company said.",
        "pubDate": "2025-09-18T13:09:58Z",
        "displayTime": "2025-09-18T13:09:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/drug-distributor-mckesson-restructure-segments-130958006.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/drug-distributor-mckesson-restructure-segments-130958006.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T12:00:00+00:00",
    "headline": "McKesson Announces New Organizational Structure",
    "summary": "IRVING, Texas, September 18, 2025--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. The new reporting structure enhances strategic alignment and transparency, supporting optimizing portfolio management to drive sustainable long-term value creation for shareholders.",
    "url": "https://finance.yahoo.com/news/mckesson-announces-organizational-structure-120000705.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "bdcb672a-11a7-3f9f-8738-fab32156763e",
      "content": {
        "id": "bdcb672a-11a7-3f9f-8738-fab32156763e",
        "contentType": "STORY",
        "title": "McKesson Announces New Organizational Structure",
        "description": "",
        "summary": "IRVING, Texas, September 18, 2025--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. The new reporting structure enhances strategic alignment and transparency, supporting optimizing portfolio management to drive sustainable long-term value creation for shareholders.",
        "pubDate": "2025-09-18T12:00:00Z",
        "displayTime": "2025-09-18T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2aabb1c4f61c8acce4920bdbf01daf22",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fQUA1ZJswlKkmRtC_8mD0Q--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2aabb1c4f61c8acce4920bdbf01daf22.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lh2hHak98.JIx0WUrafTkw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2aabb1c4f61c8acce4920bdbf01daf22.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-announces-organizational-structure-120000705.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-announces-organizational-structure-120000705.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T13:09:58+00:00",
    "headline": "Drug distributor McKesson to restructure segments to focus on high-margin businesses",
    "summary": "The restructuring will reflect how CEO Brian Tyler will allocate resources and assess performance going forward, but does not affect previously issued financial statements or historical earnings per share, the company said.  \"This updated reporting structure reflects a strategic evolution of our business – accelerating growth in the high-margin areas of oncology, multispecialty, and biopharma services,\" Chief Financial Officer Britt Vitalone said in a statement.  Starting this quarter, its second in fiscal 2026, the Texas-based firm will reorganize into North American pharmaceutical, oncology and multispecialty, prescription technology solutions, and medical-surgical solutions segments, the company said.",
    "url": "https://ca.finance.yahoo.com/news/drug-distributor-mckesson-restructure-segments-130958097.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "7741712d-6c91-3b59-8144-4407baeb39ac",
      "content": {
        "id": "7741712d-6c91-3b59-8144-4407baeb39ac",
        "contentType": "STORY",
        "title": "Drug distributor McKesson to restructure segments to focus on high-margin businesses",
        "description": "",
        "summary": "The restructuring will reflect how CEO Brian Tyler will allocate resources and assess performance going forward, but does not affect previously issued financial statements or historical earnings per share, the company said.  \"This updated reporting structure reflects a strategic evolution of our business – accelerating growth in the high-margin areas of oncology, multispecialty, and biopharma services,\" Chief Financial Officer Britt Vitalone said in a statement.  Starting this quarter, its second in fiscal 2026, the Texas-based firm will reorganize into North American pharmaceutical, oncology and multispecialty, prescription technology solutions, and medical-surgical solutions segments, the company said.",
        "pubDate": "2025-09-18T13:09:58Z",
        "displayTime": "2025-09-18T13:09:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/drug-distributor-mckesson-restructure-segments-130958097.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/drug-distributor-mckesson-restructure-segments-130958097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]